Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 244-249

  Tsujinaka, Toshimasa ^a,f   Fujita, Junya ^a   Ebisui, Chikara ^a   Yano, Masahiko ^a   Kominami, Eiki ^b   Suzuki, Koichi ^c   Tanaka, Keiji ^d   Katsume, Asao ^e   Ohsugi, Yoshiyuki ^e   Shiozaki, Hitoshi ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

calpain; cathepsin; proteasomes; protein degradation; ubiquitin

Indexed keywords

CALPAIN; CATHEPSIN B; CATHEPSIN L; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY MR 16 1; RECEPTOR ANTIBODY; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

EID: 13344261948     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118398     Document Type: Article

References (54)

1. Strassmann, G., M Fong, J. S. Kenney, and C. O. Jacob 1992. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89:1681-1684.
2. Strassmann, G., M. Fong, C. E. Freter, S. Windsor, F. D'Alessandro, and R. P. Nordan 1993. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J. Clin. Invest. 92:2152-2159.
3. Goodman, M. N. 1994. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc. Exp Biol Med. 205:182-185.
4. Ebisui, C., T. Tsujinaka, T. Morimoto, K. Kan, S. Iijima, M. Yano, E. Kominami, K. Tanaka, and M. Monden. 1995. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsin B and L, proteasomes) in C2C12 myotubes. Clin. Sci. (Lond). 89:431-439.
5. Tsujinaka, T., C. Ebisui, J Fujita, M Kishibuchi, T. Morimoto, A. Ogawa, A. Katsume, Y. Ohsugi, E. Kominami, and M. Monden. 1995. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem. Biophys Res. Commun 207:168-174.
6. Sehgal, P. B., G. Grieninger, and G. Tosato. 1989. Regulation of the acute-phase and immune responses: interleukin-6. Ann. NY Acad. Sci. 557:1-583.
7. Sehgal, P. B. 1990. Interleukin 6 in infection and cancer, Proc Soc Exp. Biol. Med. 195:183-191.
8. Fong, Y , L L. Moldawer, M. Marano, H. Wei, A. Barber, K Manogue, K. J Tracey, G. Kuo, D A Fischman, A. Cerami, and S. F. Lowry. 1989. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am. J. Physiol. 256:R659-R665
9. Warren, R. S , H. F. Starnes, Jr., J. L. Gabrilove, H. F. Oettgen, and M. F. Brennan. 1987. The acute metabolic effects of tumor necrosis factor administration in humans. Arch. Surg. 122:1396-1400.
10. Kettlhut, I. C., and A. L. Goldberg. 1988 Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue. J. Clin. Invest. 81:1384-1389.
11. Moldawer, L L., G. Svaninger, J. Gerlin, and K. G. Lundholm 1987. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 253:C766-C773.
12. Libert, C., P. Brouckaert, A. Shaw, and W. Fiers. 1990. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur J. Immunol 20:691-694.
13. Lundholn, K., A. C. Bylund, J. Holm, and T. Schersten. 1976. Skeletal muscle metabolism in patients with malignant tumor. Eur. J. Cancer 12.465-473.
14. Hall-Angeras, M., P. O. Hasselgren, R. V. W. Dimlich, and J. E. Fisher. 1991. Myofibrillar proteinase, cathepsinβ, and protein breakdown rates in skeletal muscle from septic rats Metab. Clin. Exp 40:302-306.
15. Lowell, B. B , N. B. Ruderman, and M. N Goodman. 1986. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle Biochem. J. 234:237-240.
16. Furuno, K., M. N. Goodman, and A. L. Goldberg. 1990. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J. Biol. Chem. 265:8550-8557.
17. Johnson, P. 1990. Calpains (intracellular calcium-activated cysteinc proteinase): structure-activity relationships and involvement in normal and abnormal cellular metabolism. Int. J. Biochem. 22:811-822.
18. Fagan, J. M., L Waxman, and A. L. Goldberg 1987 Skeletal muscle and liver contain a soluble ATP+ubiquitin-dependent proteolytic system. Biochem J. 243:335-343.
19. Sorimachi, H , T. C. Saido, and K. Suzuki. 1994. New era of calpain research. Discovery of tissue-specific calpains. FEBS Lett. 343:1-5.
20. Hershko, A., and A. Ciechanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761-807.
21. Rechsteiner, M 1991. Natural substrates of the ubiquitin proteolytic pathway. Cell. 66:615-618.
22. Wing, S. S., and A. L. Goldberg. 1993. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol 264:E668-E676.
23. Fujinami, K., N. Tanahashi, K. Tanaka, A. Ichihara, Z. Cejka, W. Baumeister, M. Miyawaki, T. Sato, and H. Nakagawa. 1994. Purification and characterization of the 26S proteasome from spinach leaves. J. Biol. Chem. 269, 25905-25910.
24. Suematsu, S., T. Matsusaka, T Matsuda, S. Ohno, J. Miyazaki, K Yamamura, T. Hirano, and T. Kishimoto. 1992. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci USA. 89:232-235
25. Yamamura, K., H. Kikutam, N. Takahashi, T. Taga, S. Akira, K. Kawai, K. Fukuchi, Y. Kumahara, T. Honjo, and T. Kishimoto. 1984. Introduction of human γ1 immunogloblin genes into fertilized mouse eggs J. Biochem. 96:357-363.
26. Matsuda, T., T. Hirano, and T. Kishimoto. 1988. Establishment of an interleukin 6(1L 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immunol 18:951-956.
27. Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K Kumaki, T. Taga, et al 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6 Proc. Natl Acad. Sci. USA. 90:11924-11928.
28. Asagoe, Y., K. Yasukawa, T. Saito, N. Maruo, K. Miyata, T. Kono, T. Miyake, T. Kato, H. Kakidani, and M. Mitani. 1988. Human B-cell stimulatory factor-2 expressed in Escherichia coil. Biotechnology 6:806-809.
29. Barrett, A. J., and H. Kirschke. 1981. Cathepsm B, cathepsin H, cathepsin L. Methods Enzymol. 80:535-561.
30. Bradford, M. M. 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254
31. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucletic acid from sources enriched in ribosomes. Biochemistry. 18:5294-5301.
32. Ishidoh, K., T. Towatari, S. Imajoh, H. Kawasaki, E, Kominami, N. Katsunuma, and K. Suzuki. 1987. Molecular cloning and sequencing of cDNA for rat cathepsin L. FEBS Lett. 223:69-73.
33. Sorimachi, H., S. Imajoh-Ohmi, Y Emori, H Kawasaki, S. Ohno, Y. Minami, and K. Suzuki. 1989. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ- types J Biol. Chem. 264:20106-20111.
34. Kanayama, H., K Tanaka, M. Aki, S. Kagawa, H. Miyaji, M Satoh, F Okada, S. Sato, N. Shimabara, and A Ichihara. 1991 Changes in expressions of proteasome and ubiquitine genes in human renal cancer cells. Cancer Res. 51. 6677-6685.
35. Tamura, T., D. H. Lee, F. Osaka, T. Fujiwara, S. Shin, C. H. Chung, K. Tanaka, and A. Ichihara. 1991. Molecular cloning and sequence analysis of cDNAs for five major subunits of human proteasomes (multi-catalytic proteinase complexes) Biochim Biophys. Acta 1089:95-102.
36. Dubiel, W., K. Ferrell, G Pratt, and M. Rechsteiner. 1992. Subunit 4 of the 26S protease is a member of a novel eukaryotic ATPase family. J Biol Chem. 267:22699-22702.
37. Dubiel, W., K. Ferrell, and M. Rechsteiner. 1993. Peptide sequencing identifies MSS1, a modulator of HIV Tat-mediated transactivation, as subunit 7 of the 26S protease. FEBS Lett. 323:276-278.
38. Kommami, E., T Tsukahara, Y Bando, and N. Katsunuma. 1985. Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J. Biochem 98:87-93.
39. Bando, Y., E. Kominami, and N. Katsunuma. 1986. Purification and tissue distribution of rat cathepsin L. J. Biochem. 100:35-42.
40. Suematsu, S., T. Matsuda, K. Aozasa, S. Akira, N. Nakano, S. Ohno, J. Miyazaki, K. Yamamura, T Hirano, and T. Kishimoto. 1989. TgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 86:7547-7551.
41. Taga, T., and T. Kishimoto. 1993. Cytokine receptors and signal transduction FASEB J. 7:3387-3396.
42. Kominami, E., K Ii, and N. Katsunuma. 1987. Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy. Am. J. Pathol. 127:461-466.
43. Tågerud, S., and R. Libelius 1985. Receptor-mediated uptake of horseradish peroxidase in innervated and denervated skeletal muscle Exp. Cell Res. 160:95-105.
44. Temparis, S , M Asensi, D. Taillandier, E. Aurousseau, D. Larbaud, A. Obled, D. Béchet, M. Ferrara, J. M. Estrela, and D Attaix. 1994. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscle of tumor bearing rats. Cancer Res 54:5568-5573.
45. Baracos, V. E., C DeVivo, D. H. R Hoyle, and A. L. Goldberg. 1995. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma Am. J Physiol. 268:E996-E1006.
46. Mitch, W. E., R. Medina, S. Grieber, R. C. May, B. K. England, S R. Price, J. L. Bailey, and A. L. Goldberg 1994. Metabolic acidosis stimulates muscle protein degradation by activating the adenosis triphosphate-dependent pathway involving ubiquitin and proteasomes J. Clin Invest 93 2127-2133.
47. Medina, R., S. S. Wing, and A. L. Goldberg. 1995. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy Biochem. J. 307:631-637.
48. García-Martínez, C., N. Agell, M. Llovera, F. J. López-Soriano, and J. M. Argilés. 1993. Tumor necrosis factor-α increases the ubiquinization of rat skeletal muscle proteins. FEBS Lett 323:211-214.
49. García-Martínez, C., M. Llovera, N. Agell. F. J. López-Soriano, and J. M. Argilés. 1994. Ubiquitin gene expression in skeletal muscle is increased by tumor necrosis factor-α. Biochem. Biophys. Res. Commun. 201:682-686.
50. García-Martínez, C . F. J. López-Soriano, and J. M. Argiles. 1993. Acute treatment with tumor necrosis factor-α induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem. 125:11-18.
51. Richard, I , O. Broux, V. Allamand, F. Fougerousse, N. Chiannilkulchai, N. Bourg, L. Brenguier, C Devaud, P. Pasturaud, C. Roudaut, et al. 1995. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81.27-10.
52. Hirata, Y., T. Taga, M. Hibi, N. Nakano, T. Hirano, and T. Kishimoto 1989. Characterization of IL-6 receptor expression by monoclonal and polyclona antibody J Immunol. 143:2900-2906.
53. Suzuki, H., K. Yasukawa, T Saito, R. Goitsuka, A Hasegawa, Y. Ohsugi, T. Taga, and T. Kishimoto 1992 Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol. 22:1989-1993.
54. Sato, K., M. Tsuchiya, J. Saldanha, Y. Koishihara, Y. Ohsugi, T. Kishimoto, and M. M. Bendig 1993. Reshaping a human antibody to inhibit the interleukin-6 dependent tumor cell growth Cancer Ret. 53-851-856.